Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00869401 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

217

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: dasatinib
DRUG: temozolomide
OTHER: placebo
RADIATION: radiation therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]